Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6794975

CN(c1ccccc1)c1cc2c(cn1)CCc1c-2nn2c1C(=O)NCC2.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.36
PIM2 Q9P1W9 2/20 0.36
MAPKAPK2 P49137 6/20 0.33
CCNA2 P20248 7/20 0.32
CDK2 P24941 7/20 0.32
CDK4 P11802 3/20 0.32
CCND3 P30281 3/20 0.32
CDK6 Q00534 2/20 0.32
NTRK1 P04629 1/20 0.31
PLK1 P53350 5/20 0.31
CCNA1 P78396 5/20 0.31
AURKA O14965 3/20 0.31
PLK3 Q9H4B4 2/20 0.31
PLK2 Q9NYY3 2/20 0.31
RXRA P19793 1/20 0.30
RXRB P28702 1/20 0.30
ULK1 O75385 1/20 0.30
TTK P33981 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4262642 0.84 MAPKAPK2 (0.33) MAPKAPK2CCNA2CDK2NTRK1PLK1
Trifluoroacetic Acid SCHEMBL6787950 0.84 PARP1 (0.35) MAPKAPK2CCNA2CDK2PLK1CCNA1
Trifluoroacetic Acid SCHEMBL6794258 0.82 GRIN2D (0.38)
Trifluoroacetic Acid SCHEMBL4256994 0.82 MAPKAPK2 (0.36) PIM1PIM2MAPKAPK2CCNA2CDK2
Trifluoroacetic Acid SCHEMBL4256992 0.82 MAPKAPK2 (0.36) PIM1PIM2MAPKAPK2CCNA2CDK2
Trifluoroacetic Acid SCHEMBL4270922 0.81 MAPKAPK2 (0.36) MAPKAPK2
Trifluoroacetic Acid SCHEMBL6791463 0.81 HRH4 (0.31)
Trifluoroacetic Acid SCHEMBL6794419 0.80 HRH4 (0.36) MAPKAPK2PLK1PLK3PLK2
Trifluoroacetic Acid SCHEMBL4258570 0.80 CCNA2 (0.40) PIM1PIM2CCNA2CDK2PLK1
Trifluoroacetic Acid SCHEMBL6798826 0.80 IKBKB (0.37) PLK1AURKAPLK3PLK2TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 MKNK2, MAPKAPK2, MAP3K2 PIM1 633/4885PIM2 370/4885MAPKAPK2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.